Ontogeny of the follicular dendritic cell phenotype and function in the postnatal murine spleen

被引:43
作者
Balogh, P
Aydar, Y
Tew, JG
Szakal, AK
机构
[1] Virginia Commonwealth Univ, Med Coll Virginia, Dept Anat, Richmond, VA 23298 USA
[2] Virginia Commonwealth Univ, Med Coll Virginia, Dept Microbiol & Immunol, Richmond, VA 23298 USA
关键词
mouse spleen; development; follicular dendritic cells; phenotype;
D O I
10.1006/cimm.2001.1874
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Follicular dendritic cells (FDCs) represent a unique cell population of antigen trapping cells restricted to follicles within the secondary lymphoid tissues. FDCs appear to be involved in the formation of primary follicles during the ontogeny of lymphoid tissue. We sought to determine the kinetics and tissue distribution of cells in the spleen of newborn mice expressing various differentiation antigens restricted to FDCs using immunohistochemistry with monoclonal antibodies (mAb) against FDCs and in vivo immune complex binding and retention. The earliest FDC-specific marker displayed was the antigenic determinant recognized by the FDC-M1 mAb, which was detectable by Day 3 prior to follicle formation on cells located around the peripheral part of the developing white pulp. The appearance of CD21/35 (complement receptor Type 2 and 1, CR1.2) was observed at the end of the first week, revealing a focal pattern in B-cell-rich areas. In addition, at that time there were some FDC-M1-positive cells in the nonfollicular part of the periarteriolar region. The administration of anti-horseradish peroxidase antibody followed by soluble antigen HRP into 7-day-old newborn mice resulted in the trapping and retention of immune complexes onto FDCs even in the absence of Fcgamma receptors. The appearance of another FDC-specific marker, FDC-M2, was observed during the second week after birth and was restricted on the cells located in the same area as CR1.2 cells. The Fcgamma receptor Type II appeared on FDCs after the second postnatal week. The above sequence of phenotypic maturation could also be observed in newborns after lethal irradiation at Day 3. This indicates that not only mature FDCs but also their precursors are highly radioresistant, and their phenotypic maturation follows a programmed path that requires only a small number of mature B cells. (C) 2001 Elsevier Science (USA).
引用
收藏
页码:45 / 53
页数:9
相关论文
共 25 条
[1]   A chemokine-driven positive feedback loop organizes lymphoid follicles [J].
Ansel, KM ;
Ngo, VN ;
Hyman, PL ;
Luther, SA ;
Förster, R ;
Sedgwick, JD ;
Browning, JL ;
Lipp, M ;
Cyster, JG .
NATURE, 2000, 406 (6793) :309-314
[2]   Ibl-7/1 [J].
Balogh, P .
HYBRIDOMA, 1999, 18 (02) :217-217
[3]   Mature follicular dendritic cell networks depend on expression of lymphotoxin β receptor by radioresistant stromal cells and of lymphotoxin β and tumor necrosis factor by B cells [J].
Endres, R ;
Alimzhanov, MB ;
Plitz, T ;
Fütterer, A ;
Kosco-Vilbois, MH ;
Nedospasov, SA ;
Rajewsky, K ;
Pfeffer, K .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (01) :159-167
[4]  
HANNA MG, 1968, J IMMUNOL, V101, P949
[5]   THE EFFECT OF AGE ON ANTIGEN RETENTION IN LYMPHOID FOLLICLES AND IN COLLAGENOUS TISSUE OF MICE [J].
HOLMES, KL ;
SCHNIZLEIN, CT ;
PERKINS, EH ;
TEW, JG .
MECHANISMS OF AGEING AND DEVELOPMENT, 1984, 25 (1-2) :243-255
[6]   Patterns of age-dependent changes in the numbers of lymph follicles and germinal centres in somatic and mesenteric lymph nodes in growing C57Bl/6 mice [J].
Hoshi, H ;
Horie, K ;
Tanaka, K ;
Nagata, H ;
Aizawa, S ;
Hiramoto, M ;
Ryouke, T ;
Aijima, H .
JOURNAL OF ANATOMY, 2001, 198 :189-205
[7]  
Kapasi ZF, 1998, J IMMUNOL, V160, P1078
[8]  
KROESE FGM, 1987, IMMUNOLOGY, V60, P597
[9]   B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals [J].
Loder, F ;
Mutschler, B ;
Ray, RJ ;
Paige, CJ ;
Sideras, P ;
Torres, R ;
Lamers, MC ;
Carsetti, R .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (01) :75-89
[10]  
MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117